Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ 202,961	$ 20	$ 326,046	$ (10)	$ (123,095)
Beginning balance, shares at Dec. 31, 2020		19,931,660
Issuance of common stock upon exercise of stock options	216		216
Issuance of common stock upon exercise of stock options, shares		103,170
Stock-based compensation	1,793		1,793
Net loss	(14,782)				(14,782)
Other comprehensive loss	7			7
Ending balance at Mar. 31, 2021	190,195	$ 20	328,055	(3)	(137,877)
Ending balance, shares at Mar. 31, 2021		20,034,830
Beginning balance at Dec. 31, 2020	202,961	$ 20	326,046	(10)	(123,095)
Beginning balance, shares at Dec. 31, 2020		19,931,660
Issuance of common stock warrant in connection with term loan facility	574
Net loss	(35,505)
Other comprehensive loss	14
Ending balance at Jun. 30, 2021	172,705	$ 20	331,281	4	(158,600)
Ending balance, shares at Jun. 30, 2021		20,080,665
Beginning balance at Mar. 31, 2021	190,195	$ 20	328,055	(3)	(137,877)
Beginning balance, shares at Mar. 31, 2021		20,034,830
Issuance of common stock upon exercise of stock options	152		152
Issuance of common stock upon exercise of stock options, shares		40,628
Issuance of common stock upon ESPP purchases	83		83
Issuance of common stock upon ESPP purchase, Shares		5,207
Issuance of common stock warrant in connection with term loan facility	574		574
Stock-based compensation	2,417		2,417
Net loss	(20,723)				(20,723)
Other comprehensive loss	7			7
Ending balance at Jun. 30, 2021	172,705	$ 20	331,281	4	(158,600)
Ending balance, shares at Jun. 30, 2021		20,080,665
Beginning balance at Dec. 31, 2021	125,957	$ 20	339,218	(64)	(213,217)
Beginning balance, shares at Dec. 31, 2021		20,317,204
Issuance of common stock upon exercise of stock options	29		29
Issuance of common stock upon exercise of stock options, shares		12,065
Issuance of common stock upon vesting of restricted stock units, net, shares		22,115
Stock-based compensation	2,512		2,512
Net loss	(25,565)				(25,565)
Other comprehensive loss	(192)			(192)
Ending balance at Mar. 31, 2022	102,741	$ 20	341,759	(256)	(238,782)
Ending balance, shares at Mar. 31, 2022		20,351,384
Beginning balance at Dec. 31, 2021	125,957	$ 20	339,218	(64)	(213,217)
Beginning balance, shares at Dec. 31, 2021		20,317,204
Net loss	(50,619)
Other comprehensive loss	(254)
Ending balance at Jun. 30, 2022	80,185	$ 20	344,319	(318)	(263,836)
Ending balance, shares at Jun. 30, 2022		20,367,363
Beginning balance at Mar. 31, 2022	102,741	$ 20	341,759	(256)	(238,782)
Beginning balance, shares at Mar. 31, 2022		20,351,384
Issuance of common stock upon ESPP purchases	43		43
Issuance of common stock upon ESPP purchase, Shares		15,979
Withholding taxes related to restricted stock units	(69)		(69)
Stock-based compensation	2,586		2,586
Net loss	(25,054)				(25,054)
Other comprehensive loss	(62)			(62)
Ending balance at Jun. 30, 2022	$ 80,185	$ 20	$ 344,319	$ (318)	$ (263,836)
Ending balance, shares at Jun. 30, 2022		20,367,363